Assessment of methodological quality of economic evaluations in belgian drug reimbursement applications.
OBJECTIVES: This paper aims to assess the methodological quality of economic evaluations included in Belgian reimbursement applications for Class 1 drugs. MATERIALS AND METHODS: For 19 reimbursement applications submitted during 2011 and Spring 2012, a descriptive analysis assessed the methodologica...
Main Author: | Steven Simoens |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3875546?pdf=render |
Similar Items
-
Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
by: Evelien Moorkens, et al.
Published: (2020-01-01) -
Critical Reflections on Reimbursement and Access of Advanced Therapies
by: Steven Simoens, et al.
Published: (2022-05-01) -
How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries
by: Alessandra Blonda, et al.
Published: (2022-07-01) -
Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study.
by: Elfi De Weerdt, et al.
Published: (2017-01-01) -
Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review
by: Khadidja Abdallah, et al.
Published: (2021-04-01)